Valuation: MINDESTA

Market Cap 3.4M 3.02M 2.83M 2.58M 4.85M 328M 4.92M 34.21M 13.24M 167M 12.78M 12.5M 536M P/E 2024
-11.9x
P/E 2025 -22.2x
Enterprise Value 3.41M 3.03M 2.83M 2.58M 4.86M 328M 4.92M 34.24M 13.26M 167M 12.79M 12.52M 537M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
50.43%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member 71 2014-09-08
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+4.16%-0.36%+49.37%+94.17% 74.46B
-0.61%+0.81%+27.25%+80.21% 60.14B
-2.54%-1.65%+4.86%+33.32% 48.15B
-2.68%-5.59%+27.41%+33.92% 44.25B
+1.48%+3.85%+352.57%+693.08% 43.99B
-1.51%-0.16%+7.23%+101.34% 41.61B
+3.32%+3.49%+11.18%+51.23% 29.97B
+4.77%+6.16%+36.77%+22.78% 29.31B
-3.49%-9.51%-25.32%+333.54% 24.93B
Average +0.30%+1.97%+54.59%+160.40% 44.09B
Weighted average by Cap. +0.45%+1.83%+58.86%+151.63%

Financials

2024 2025
Net sales - -
Net income -250K -222K -208K -189K -357K -24.09M -361K -2.51M -973K -12.27M -939K -919K -39.41M -156K -138K -129K -118K -222K -15.01M -225K -1.57M -606K -7.64M -585K -573K -24.55M
Net Debt 16.82K 14.94K 13.97K 12.73K 23.97K 1.62M 24.3K 169K 65.42K 825K 63.15K 61.78K 2.65M 3.46K 3.07K 2.87K 2.62K 4.92K 333K 4.99K 34.72K 13.44K 169K 12.97K 12.69K 544K
Logo MINDESTA
CTT Pharmaceutical Holdings, Inc. specializes in drug delivery systems technology within the pharmaceutical industry. Its technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. It rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its oral film technology drug delivery system can be provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. Its drug delivery system technology includes nicotine, vitamins, pharmaceuticals, and many other actives. It offers oral thin strips for pain management and inflammation indications, such as arthritis. VetWafe is used for pain management for pet markets. It is a thin film for treating dogs and cats.
Employees
-